Novavax Inc. closed 71.00% below its 52-week high of $23.86, which the company reached on June 6th.

In a move that caught much of the medical world off guard, the CDC has stepped back from recommending Covid-19 vaccinations for healthy children and pregnant women. Health and Human […] The post CDC ...

“We are evolving our organization’s capabilities and different roles across the company, including those on our leadership ...

Just a week after the FDA updated its stance on new COVID-19 | The CDC's recommended immunization schedule no longer includes ...

The move underscores the profound impact HHS Secretary Robert F. Kennedy is exerting on immunizations in the U.S.

The Centers for Disease Control and Prevention will no longer recommend routine Covid shots for healthy children and pregnant ...

The news comes after the Trump Administration recently said it would limit approval for COVID-19 boosters to some populations ...

The agency recommends manufacturers update their vaccines to target the JN.1 strain. At the same time, HHS head Robert F.

Novavax, Inc. (“Novavax”) announced that FDA approved its Biologics License Application (“BLA”) for Nuvaxovid™ for active ...

As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future ...